Tenmile β Full Portfolio
42 tracked investments Β· listed companies and verified rows first
Revagenix is a precision-therapeutics company that develops drugs for serious chronic diseases, starting from the underlying biology and unmet clinical needs.
BiotechDeep TechHealthtechMedical Devices
Ryan Cirz(Co-founder & CEO)Andrew McCandlish(Co-founder & COO)Peter Smith(Chief Scientific Officer)Daniel Cloutier(VP, Development)
AdvanCell develops radioisotope-based therapies, using Th-228 sourced through the U.S.
BiotechHealthtechMedical DevicesCambridge, US
Andrew Adamovich(Director)Philina Lee(Executive Officer, Director)Aaron Pickett(Executive Officer)
BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)
Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases.
Biotech
BiotechBoston, US
Andrew Fedder(Executive Officer, Director)Adam Friedman(Executive Officer, Director)Brian Piper(Executive Officer, Director)
Antares Therapeutics discovers and develops precision medicines, with a focus on small molecule therapies targeting previously undruggable oncology targets and other serious diseases.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Adam Friedman(Chief Executive Officer)in
AusBiotech is a membership and advocacy organization representing Australia's life sciences ecosystem, including early-stage discovery, development, commercialization, and manufacturing organizations.
BiotechMedical DevicesBrisbane, AU
Capital Brief is a business and politics publication focused on Australia's economy and its intersection with entrepreneurship, capital allocation, and policy.
Media & EntertainmentSydney, AU
Chris Janz(Chief Executive Officer)inDavid Eisman(Chief Business Officer)inJohn McDuling(Editor-in-Chief)
Carina Biotech develops cell and gene therapy treatments, with ongoing Phase 1/2a clinical trials and research in CAR-TCR technology.
Biotech
Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.
AI & Machine LearningBiotechDeep Tech
Commercial manufacturer of bilateral weight-bearing tomography scanners for orthopaedics.
BiotechMelbourne
Gregory Brown(Director)Ura Phillip Stephen Auckland(Company Secretary)David Seeman(Director)Waradana Malitha Hashan De Silva(Director)Robert Lilley(Director)
CurveBeam AI develops cone beam CT point-of-care medical imaging systems and deep learning software for bone and joint analysis, aiding orthopedic surgeons with 3D deformity measurements and bone microstructure analysis.
AI & Machine LearningHealthtechMedical Devices
Clinical services company collecting patient data and developing novel drug and care models, including MDMA-assisted treatment for PTSD.
Online platform connecting users with accredited ADHD specialists for diagnosis and treatment plans.
Lumos Diagnostics develops rapid, cost-effective point-of-care diagnostic tests and digital reader platforms for healthcare professionals to assess and manage medical conditions.
BiotechHealthtechMedical Devices
Doug Ward(CEO)Paul Kase(Chief Commercial Officer)
Mindset Health develops digital health programs using hypnotherapy and mind-body medicine to help patients manage gastrointestinal disorders and improve health outcomes.
Digital HealthHealthtechMedical DevicesMental HealthWellness & FitnessMelbourne, AU
Alex Naoumidis(Co-founder & Co-CEO)inChris Naoumidis(Founder)in
Oncko develops machine learning and experimental platforms to discover optimized multi-drug cancer treatment combinations by screening against resistance mechanisms.
AI & Machine LearningBiotechDeep Tech
Atray Dixit(Co-founder, CEO)inBill Grossman(Co-founder, Strategic Advisor)in
Digital care management program using daily motivation to drive medication adherence in high-risk chronic condition members.
Perx provides a digital care management platform for medically complex and high-risk members to improve treatment adherence and health outcomes.
Digital HealthHealthtechSaaS
SpeeDx provides multiplexing technology platforms and diagnostic assays for detecting infectious disease pathogens, including customized solutions for respiratory infections, sexually transmitted infections, gastrointestinal illness, and antimicrobial resistance markers.
BiotechMedical Devices
Proton Intelligence develops CKMβ’, a continuous monitoring medical device drawing on biosensing and minimally invasive microdevice technology for clinical use.
Deep TechDigital HealthHealthtechMedical Devices
Paul(Veteran IVD technologist)Bill
Developing next-generation cell surface degraders to target previously undruggable proteins in autoimmune conditions and cancers.
Developing a drug to remyelinate neurons in multiple sclerosis patients.
Halle Tecco(Founder)
Multiplex diagnostic testing kits used by pathology labs for respiratory diseases and STIs.
Developing a gene therapy for advanced forms of basal cell carcinoma skin cancer.
Clinical-stage neuroscience company developing ketamine-inspired compounds for depression without hallucinogenic effects.
Venture fund investing seed to pre-IPO in companies from the University of Melbourne ecosystem, focused on life and physical sciences.
Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US
Alice Zhang(Founder/CEO)inEmily Ripka(Head of Product & Engineering)Jason Chen(Cofounder)
Manufacturer of 5HT2A small molecules for mental health disorders using a computational approach.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.